IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
CORONA Remedies Ltd.
Issue Open Date 08-Dec-25  
Issue Closing Date 10-Dec-25  
Application Money 100  
Allotment Money  
Price Band 1008 - 1062  
Minimium Application No. 14  
Issue Size (Shares) 6504980  
Market Lot 1.00  
Objective
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors       NA  
Qualified Institutional Buyers       NA  
Retail Individual Investors       NA  
Business Description
We are an India-focused branded pharmaceutical formulation company engaged in developing, manufacturingand marketing products in women’s healthcare, cardio-diabeto, pain management, urology and other therapeuticareas. According to the Industry Report, we are t
more...
Promoter's Holding
Total Share Capital   44338558  
Offered to Public   6171101  
Promoter's Holding (Pre-Issue)   72.5  
Promoter's Holding (Post-Issue)    
Address
C – Mondeal Business Park
Near Gurudwara
S. G. Highway
Thaltej
Ahmedabad ,
Gujarat ,
380059
Phone: 079 4023 3000
Email: complianceofficer@coronaremedies.com
Website: www.coronaremedies.com
Registrar
Bigshare Services Pvt Ltd
Office No S6-2
6th Floor
Pinnacle Business Park
Next to Ahura Centre
Mahakali Caves Road
Andheri (E)
Mumbai
Listed at
BSE, NSE
Lead Manager
IIFL Capital Services Ltd.
JM Financial Ltd.
Kotak Mahindra Capital Co Ltd
Promoters
Ankur Kirtikumar Mehta
Kirtikumar Laxmidas Mehta
Niravkumar Kirtikumar Mehta
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.